<DOC>
	<DOCNO>NCT02912728</DOCNO>
	<brief_summary>The primary objective study compare efficacy safety CGM alone CGM combine family behavioral intervention control group use home blood glucose monitoring ( BGM ) alone .</brief_summary>
	<brief_title>Strategies Enhance New CGM Use Early Childhood ( SENCE )</brief_title>
	<detailed_description>Although prior study demonstrate continuous glucose monitoring ( CGM ) use result improved glycemic control child &lt; 8 year age , many barrier CGM efficacy age group may due problem wearability accuracy prior generation device , well set glycemic target aim primarily prevent hypoglycemia cost . There may also behavioral barrier consistent effective CGM use age range . The goal study assess impact CGM alone CGM combine family behavioral intervention focus support CGM use glycemic control young child T1D compare usual care without CGM .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>1 . Clinical diagnosis insulin dependent presume autoimmune type 1 diabetes investigator 2 . Age 2 &lt; 8 year 3 . Diabetes duration ≥ 6 month 4 . Total daily insulin ≥ 0.3 unit per kg per day 5 . HbA1c 7.0 % &lt; 10.0 % ( Point care device local lab measure within 30 day screen visit use assess eligibility ) 6 . Insulin regimen involve either use insulin pump least 3 multiple daily injection basal bolus ( meal time ) analogue insulin last 3 month , plan switch modality insulin administration next 6 month ( e.g. , injection user switch pump , pump user switch injection ) . 7 . Perform least 3 blood glucose meter check per day selfreport screen meter download blind CGM run 8 . Not currently use plan begin noninsulin medication blood glucose lower course study 9 . Parent guardian comprehend write spoken English ( This requirement due fact questionnaire use outcome measure validate version language , intervention deliver English RCT ensure standardization/fidelity check across site ) . 10 . Parent understand study protocol agree 11 . No expectation participant/parent move area clinical center next 12 month , unless move area serve another study center . 1 . Use unblinded personal CGM , outside research study , part realtime diabetes management last 30 day 2 . Unable use CGM device minimum number hour blind runin period skin reaction adhesive would preclude participation randomize trial 3 . The presence significant medical disorder use medication oral/inhaled glucocorticoid judgment investigator affect wear sensor completion aspect protocol . 4 . More 1 episode SH DKA past 6 month ( include DKA time dx ) . 5 . The presence follow disease : Asthma treat systemic daily inhale corticosteroid last 6 month ( Intermittent treatment inhale corticosteroid exclude subject enrollment ) Cystic fibrosis ( Adequately treat thyroid disease celiac disease exclude subject enrollment ) 6 . Inpatient psychiatric treatment past 6 month either child participant primary care giver 7 . Need use acetaminophen acetaminophencontaining product regular basis 6 month trial 8 . Participation parent child diabetes relate intervention study past 6 week . 9 . Any medical , psychological social situation per investigator discretion may difficult family child participate fully intervention 10 . Another member household participate study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>7 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>